␣ 1 -ADRENERGIC RECEPTORS (␣ 1 -ARs) are G protein-coupled receptors and mediate some of the physiological actions of norepinephrine. Several studies have demonstrated that ␣ 1 -ARs can activate a variety of effectors including phospholipase C (PLC), phospholipase D, phospholipase A 2 , cAMP metabolism, and various ion channels (1, 2, 4, 18, 23) . Moreover, extracellular Ca 2ϩ influx through nonselective cation channels (NSCCs) plays critical roles for norepinephrine-induced arachidonic acid release and cell proliferation in Chinese hamster ovary cells stably expressing ␣ 1A -ARs (CHO-␣ 1A ) (12, 13) . Thus, it is important to elucidate activation mechanisms of NSCCs by norepinephrine. In the present study, we focused on investigating which G protein subtypes were involved in the activation of NSCCs. We have recently shown that a sustained increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) caused by norepinephrine results from Ca 2ϩ entry through NSCCs in CHO-␣ 1A (12) . In particular, NSCCs are sensitive to LOE-908 (5) and resistant to SK&F 96365 (20) . ␣ 1 -ARs are functionally coupled with G q in CHO cells (12, 24) . However, it remains unclear whether ␣ 1 -ARs are coupled with other subtypes of G ␣ proteins in CHO cells. Dominant negative mutants of G 12 and G 13 (G 12 G228A and G 13 G225A, respectively) inhibit endothelin-1-induced actin stress fiber formation and NSCC activation in CHO cells stably expressing endothelin A receptor and endothelin B receptor (CHO-ET A and CHO-ET B , respectively) (8, 16, 17) . Therefore, we used G 12 G228A and G 13 G225A to clarify the involvement of G 12 and G 13 for NSCCs activation by norepinephrine in this study. In addition, we examined the role of G 12 and G 13 on norepinephrine-induced arachidonic acid release in this study. We demonstrated recently that G 12 is involved in endothelin-1-induced arachidonic acid release in CHO-ET A (14) .
MATERIAL AND METHODS
Cell culture. We used CHO-␣1A, which were constructed as described previously (12) . Cells were maintained in F-12 medium supplemented with 10% fetal calf serum (FCS) under a humidified 5% CO 2-95% air atmosphere.
Measurement of [Ca 2ϩ ]i. [Ca 2ϩ ]i was measured using a fluorescent probe fluo 3. The measurements of fluorescence by a CAF 110 spectrophotometer (JASCO, Tokyo, Japan) and an Attofluor RatioVision real time digital fluorescence analyzer (Atto Instruments, Potomac, MD) were performed exactly as described previously (7) .
Microinjection of G 12G228A and G13G225A. G12G228A and G 13G225A in pcDNA 3.1(ϩ) were constructed as described previously (8, 14) . Microinjection of G 12G228A and G13G225A was performed as described previously (8, 14) . Briefly, cells were seeded onto glass coverslips coated with fibronectin (Iwaki Glass, Chiba, Japan), which were marked with a cross to facilitate the localization of injected cells, and incubated overnight in Ham's F-12 medium containing 1% FCS. Plasmids (100 ng/l) encoding for G 12G228A and G 13G225A were microinjected into cell nuclei. As a control, expression plasmids without inserts were microinjected in an adjacent field on the same coverslip. Microinjection was performed using a manual microinjection system (Eppendorf-5 Prime, Hamburg, Germany) equipped with an Axiovert 100 inverted microscope (CarlZeiss, Frankfurt, Germany). (12) . Briefly, cells in 100-mm dishes were incubated overnight with [ 3 H]arachidonic acid (final concentration, 1 Ci/ml). After washing, norepinephrine was added for 5 min. The medium was then removed, acidified with 100 l of 1N formic acid, and extracted with 3 ml of chloroform. The extracts were evaporated to dryness, resuspended in 50 l of chloroform, and applied to silica gel plates for thin-layer chromatography (Merck, Darmstadt, Germany). The plates were developed in heptane/ diethyl ether/acetic acid (vol/vol; 75:25:4). The distance of movement was visualized with iodine vapor. The plate was scraped, and the radioactivity was counted with a liquid scintillation counter.
Materials. Constitutively active G 12 or G13 in pcDNA3(ϩ) was kindly provided by Dr. Manabu Negishi (Kyoto University, Japan). Welfide (Osaka, Japan) kindly provided Y-27632. Other chemicals were obtained commercially.
Statistical analysis. All results were expressed as means Ϯ SE. The data were subjected to a two-way analysis of variance. When a significant F value was encountered, the Newman-Keuls' multiple range test was used to test for significant differences between treatment groups. A probability level of P Ͻ 0.05 was considered statistically significant.
RESULTS

Effects of U73122 on norepinephrine-induced activation of Ca
2ϩ channels. At first, we examined the involvement of G q /PLC-dependent pathway in NSCCs activation by norepinephrine based on the data that ␣ 1 -ARs are functionally coupled with G q in CHO cells (13, 24) . Norepinephrine at 100 nM induced a biphasic increase in [Ca 2ϩ ] i consisting of an initial transient peak and a subsequent sustained increase in CHO-␣ 1A (Fig. 1A) . On the other hand, 100 nM norepinephrine induced only a sustained increase in [Ca 2ϩ ] i in CHO-␣ 1A treated with 10 M U73122, a specific inhibitor of PLC (Fig. 1B) . The transient increase in [Ca 2ϩ ] i was not detected in these cells (Fig. 1, B and C). The magnitudes of sustained increase in [Ca 2ϩ ] i in U73122-treated cells were similar to those in control cells (Fig. 1D) . The inactive analog of U73122, U73343, also failed to inhibit norepinephrine-induced sustained increase in [Ca 2ϩ ] i (data not shown). Effects of G 12 G228A and G 13 G225A on norepinephrineinduced activation of Ca 2ϩ channels. To investigate whether G 12 and G 13 are involved in the activation of NSCCs, we investigated the effects of G 12 G228A and G 13 G225A on the norepinephrine-induced increase in [Ca 2ϩ ] i in CHO-␣ 1A . In this experiment, G 12 G228A and G 13 G225A were microinjected into CHO-␣ 1A , and the norepinephrine-induced increase in [Ca 2ϩ ] i in these cells was analyzed using Attofluor RatioVision real time digital fluorescence analyzer. Norepinephrine at 100 nM induced a biphasic increase in [Ca 2ϩ ] i consisting of an initial transient peak and a subsequent sustained increase in CHO-␣ 1A microinjected with G 12 G228A (Fig. 2A) . On the other hand, 100 nM norepinephrine induced only a transient increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with G 13 G225A (Fig. 2, B and D) . The magnitudes of transient increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with G 13 G225A were similar to those in CHO-␣ 1A and CHO-␣ 1A microinjected with G 12 G228A (Fig. 2C) . On the other hand, norepinephrine failed to induce a sustained increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with constitutively active G 12 or G 13 (data not shown).
Effects of Y-27632 and wortmannin on norepinephrineinduced activation of Ca
2ϩ channels. According to the data using G 13 G225A, G 13 plays important roles in NSCCs activation by norepinephrine. It is generally accepted that Rho/Rhokinase (ROCK) pathway is a downstream target of G 13 (21) . We examined the effects of ROCK on norepinephrine-induced increase in [Ca 2ϩ ] i in CHO-␣ 1A . In this experiment, Y-27632 was used as a specific inhibitor of ROCK (22) . Y-27632 at 10 M did not affect to the norepinephrine-induced transient and sustained increase in [Ca 2ϩ ] i (Fig. 3, A-C) . Based on the previous data that phosphoinoditide 3-kinase (PI3K) is involved in some types of NSCCs activation by endothelin-1 in CHO cells stably expressing endothelin receptors (9, 10), we examined the effects of wortmannin, an inhibitor of PI3K, on norepinephrine-induced increase in [Ca 2ϩ ] i in CHO-␣ 1A . Wortmannin at 1 M failed to inhibit the norepinephrine-induced transient and sustained increase in [Ca 2ϩ ] i (Fig. 3, D-F) . Effects of G 12 G228A and G 13 G225A on norepinephrineinduced arachidonic acid release. G 12 G228A or G 13 G225A was transiently transfected for evaluating the role of G 12 or G 13 , respectively, in norepinephrine-induced arachidonic acid release. For this purpose, we used MBS Mammalian Transfection Kit. When we transfected green fluorescent protein (GFP) with this method, around 65% of cells were GFP positive (data not shown). The magnitudes of norepinephrine-induced arachidonic acid release in CHO-␣ 1A transfected with G 13 G225A were around 20% of those in CHO-␣ 1A (Fig. 4) . In contrast, G 12 G228A failed to inhibit norepinephrine-induced arachidonic acid release (Fig. 4) . The magnitudes of norepinephrineinduced arachidonic acid release in CHO-␣ 1A transfected with only vector were similar to those in CHO-␣ 1A (data not shown).
DISCUSSION
Norepinephrine at 100 nM evoked an increase in [Ca 2ϩ ] i consisting of two components: a rapid initial transient peak and a sustained phase (Fig. 1A) . The sustained phase was abolished by the removal of extracellular Ca 2ϩ , whereas the transient peak remained unaffected (12) . These results indicate that the sustained phase is due to a transmembrane Ca 2ϩ influx, whereas the transient phase is the result of Ca 2ϩ mobilization from the intracellular stores as noted previously (6) . Extracellular Ca 2ϩ influx through NSCCs plays essential role in norepinephrine-induced cell proliferation and arachidonic acid release in CHO-␣ 1A (12, 13) . Therefore, it is important to reveal the intracellular activation mechanisms of NSCCs by norepinephrine. In this study, we focused on which G proteins were involved in NSCCs activation by norepinephrine in CHO-␣ 1A . Judging from the data of [ 3 H]inositol phosphate accumulation (12), ␣ 1A -ARs couple with G q in CHO cells. In addition, it is generally accepted that PLC is activated downstream of G q (2, 24) . Therefore, at first, we examined the involvement of G q /PLC-pathway in NSCCs activation by norepinephrine. Judging from the data that 1) norepinephrine evokes only sustained increase in [Ca 2ϩ ] i in U73122-treated CHO-␣ 1A (Fig. 1B) and 2) the magnitudes of the sustained increase in [Ca 2ϩ ] i in U73122-treated CHO-␣ 1A were similar to those in control CHO-␣ 1A (Fig. 1D) , the G q /PLC-pathway plays an important role in norepinephrine-induced Ca 2ϩ release from the intracellular stores, whereas activation of NSCCs is independent of the G q /PLC-pathway. Because G 12 and G 13 are involved in NSCCs activation by endothelin-1 in CHO cells stably expressing endothelin receptors (8, 16) and C6 glioma cells (11), we examined the effects of G 12 and G 13 on NSCCs activation by norepinephrine using G 12 G228A and G 13 G225A. Based on the data that 1) the magnitudes of the transient increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with G 12 G228A or G 13 G225A were similar to those in the control CHO-␣ 1A (Fig. 2) , 2) norepinephrine failed to induce a sustained increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with G 13 G225A (Fig. 2,  B and D) , and 3) the magnitudes of the sustained increase in [Ca 2ϩ ] i in CHO-␣ 1A microinjected with G 12 G228A were similar to those in the control CHO-␣ 1A (Fig. 2, A and D) , ␣ 1A -ARs may couple with G 13 , but not with G 12 , in CHO cells, and the G 13 -dependent pathway plays an important role for activation of NSCCs, whereas norepinephrine-induced mobilization of Ca 2ϩ from the intracellular Ca 2ϩ store may not be involved. Based on the data using constitutively active G 12 or G 13 , NSCCs have already been activated before adding norepinephrine. These data may support that ␣ 1A -ARs may couple with G 13 , but not with G 12 , in CHO cells. A previous report demonstrates that G 12 /G 13 mediates ␣ 1 -AR-induced cardiac hypertrophy (19) . It is interesting that the ␣ 1 -AR may be capable of coupling to different G proteins in different cell types. Because the Rho/ROCK pathway is a downstream target of G 13 (21) , we investigated the effects of ROCK on the activation of NSCCs by norepinephrine using Y-27632. Based on the lack of sensitivity to Y-27632, G 13 activates NSCCs via ROCK-independent signaling pathways. Further study is needed to identify the regulators downstream of G 13 for activation of NSCCs. PI3K is involved in some types of NSCCs activation by endothelin-1 in CHO cells stably expressing endothelin receptors (9, 10) . However, PI3K is not involved in NSCCs activation by norepinephrine in CHO-␣ 1A judging from the lack of sensitivity to wortmannin (Fig. 3) .
Extracellular Ca 2ϩ influx through NSCCs plays a critical role for norepinephrine-induced arachidonic acid release in CHO-␣ 1A (12) . Therefore, we examined the effects of G 13 on norepinephrine-induced arachidonic acid release. Disruption of signaling through endogenous G 13 by its dominant negative mutant (G 13 G225A) inhibited norepinephrine-induced arachidonic acid release in CHO-␣ 1A (Fig. 4) , indicating that activation of arachidonic acid release is mediated by G 13 . In contrast, G 12 G228A failed to inhibit norepinephrine-induced arachidonic acid release (Fig. 4) . Therefore, G 13 , but not G 12, plays important roles in norepinephrine-induced arachidonic acid release. Norepinephrine-induced arachidonic acid release was not inhibited completely by G 13 G225A in this study (Fig. 4) . We think that this is because G 13 G225A is not transfected to all cells. However, another possibility is that norepinephrine induces arachidonic acid release with another unknown pathway in CHO-␣ 1A . Further research is necessary to confirm this.
Next, we summarized the pharmacological characteristics and activation mechanisms of Ca 2ϩ channels activated by norepinephrine in CHO-␣ 1A and by endothelin-1 in CHO-ET A and CHO-ET B (Table 1) . On the basis of the sensitivity to Ca 2ϩ channel blockers, SK&F 96365 and LOE 908, NSCCs activated by norepinephrine in CHO-␣ 1A (11) and NSCC-1 activated by endothelin-1 in CHO-ET A and CHO-ET B (15) have the same pharmacological sensitivities (LOE 908-sensitivity and SK&F 96365-resistance). In addition, the activation mechanisms of NSCCs by norepinephrine in CHO-␣ 1A (Fig. 2) are similar to those of NSCC-1 in CHO-ET B (8) at the following points. 1) Both channels are activated via G 13 -dependent and G q /PLC-independent pathways. 2) Neither Rock-nor PI3K-dependent pathway are involved in these channels' activation. These results indicate that ␣ 1A -ARs and endothelin B receptors may activate some types of NSCCs (NSCC-1) via the same pathways in CHO cells. Moreover, NSCCs activated by norepinephrine are included in NSCC-1. 
